University of Miami Health System, Miller School of Medicine

University of Miami Launches COVID-19 Heart Program

Newswise — “Your heart health may have been affected in several ways,” said Jeffrey Goldberger, M.D., M.B.A., professor of medicine and chief of the Cardiovascular Division. “If you tested positive for COVID-19, you may be wondering if your heart has been damaged by the virus or the inflammation that occurred with the infection. If you did not have COVID-19, you might have experienced troubling symptoms, like chest pain, shortness of breath, palpitations, or loss of consciousness, but delayed seeking care due to COVID-19 concerns. You might also be concerned with your overall heart health, and would like an evaluation.”

Carlos E. Alfonso, M.D., associate professor of medicine and director of the cardiology fellowship training program at UM/Jackson Memorial Hospital, said the UM specialists have been conducting thorough heart evaluations for many years. “We have been very successful in identifying people with early signs of coronary artery disease who require further treatment and prevention to avoid progression of the disease and its deleterious consequences,” he said.

To address COVID-19 safety concerns, the University of Miami Health System is taking the necessary precautions for patients to receive care in a safe environment. Examination rooms are carefully disinfected, and doctors and nurses wear personal protective equipment such as goggles, gloves, and face masks. Non-COVID patients are kept in areas separate from COVID-19 patients, and anyone with a suspected case of coronavirus is treated in an isolated area. “You can feel secure in scheduling a heart evaluation at our cardiology clinics,” Dr. Alfonso said.

COVID-19 Positive Patients

The COVID-19 Heart Program is designed to address three types of individual concerns, beginning with patients who have tested positive and have recovered from the coronavirus infection.

“Our clinical studies indicate that approximately one-third of patients who have been hospitalized for COVID-19 infection show evidence of inflammation of the heart,” said Dr. Goldberger. “How the heart heals from this inflammation is currently unknown, but we do know how to address certain findings to prevent long-term complications. Whether people with less severe cases of COVID-19 infection that did not require hospitalization could also have had inflammation of the heart is unknown.”

Reports from the American College of Cardiology (ACC) indicate that cardiovascular disease and hypertension are significant risk factors for COVID-19 patients. The UM cardiology specialists are now screening individuals with COVID-19 for signs of immediate or potential future damage to the heart.

“We know that many viral infections leave their mark on the heart,” said Dr. Goldberger. For instance, inflammation of the fatty epicardial tissues surrounding the heart is associated with coronary artery disease and atrial fibrillation. “You might not realize this damage has occurred,” he added.

People who test positive for COVID-19 and have other chronic health issues, such as hypertension, diabetes, or cancer, may be at particularly high risk for heart damage, according to Dr. Goldberger. “We have many types of medications to treat inflammation and other types of heart disease. But it’s very important to identify these issues at an early stage so our specialists can provide preventive care and reduce the risk of a dangerous problem.”

Untreated Heart Disease during COVID-19

During the COVID-19 pandemic, cardiologists across the country have seen an estimated 40 percent reduction in the number of heart attacks treated in hospitals. The same trend has occurred with other cardiac conditions, such as atrial fibrillation and syncope (loss of consciousness) that are typically treated in the hospital.

“Many people with serious symptoms have stayed home rather than go to the emergency room,” said Dr. Goldberger. “While we can’t go back in time to treat a dangerous heart condition, we can provide effective ongoing care to address the underlying heart problems that were not addressed during the COVID-19 pandemic.”

If you had prolonged periods of chest pain or pressure, jaw pain, shortness of breath, lightheadedness, palpitations, or fainting while at home, the UM heart specialists can conduct a comprehensive evaluation to figure out what happened, and initiate necessary treatments to prevent future heart attacks or other heart problems.

Heart Health Concerns  

For many people, the pandemic has led to an increased interest in their overall health. For individuals with concerns about their heart due to family history or risk factors such as diabetes, high blood pressure, smoking, obesity, and lack of exercise, now is as good a time as any to assess risk for heart disease and put a plan in place to lower the risk. Many questions have also been raised about the use of certain blood pressure medications and the risks of COVID-19 related to some of these conditions. “As the virus may linger with us for a while, now is also a good time to get all your questions and concerns addressed,” said Dr. Goldberger.

The UM cardiologists can help individuals understand their risk for heart disease, added Dr. Alfonso. “For instance, we offer calcium scoring studies to determine the extent of atherosclerosis, the buildup of plaque on the coronary arteries that could lead to a heart attack. That’s one of the ways we can refine risk beyond just measuring cholesterol levels in the blood.”

A cardiology evaluation may also uncover evidence of a heart valve problem or an irregular heartbeat, Dr. Alfonso said. “We have a wide range of therapies to treat these conditions. If you are concerned about your heart, a thorough evaluation can provide answers to your questions.”

To learn more, visit the COVID-19 Heart Program site.

To make an appointment for the COVID-19 Heart Program, call 305-2-HEART-U (305-243-2788).

 




Filters close

Showing results

110 of 2816
access_time Embargo lifts in 2 days
Embargo will expire: 6-Aug-2020 11:00 AM EDT Released to reporters: 5-Aug-2020 4:25 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 6-Aug-2020 11:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise:Video Embedded uab-department-of-pathology-develops-strategy-to-support-guidesafe-entry-testing-process-more-than-200-000-samples
VIDEO
Released: 5-Aug-2020 4:10 PM EDT
UAB Department of Pathology develops strategy to support GuideSafe™ Entry Testing, process more than 200,000 samples
University of Alabama at Birmingham

This strategy will allow for ramping up testing capacity tenfold for the next 20-plus days leading up to the start of school.

Newswise: 239458_web.jpg
Released: 5-Aug-2020 2:50 PM EDT
New findings on enzymes with important role in SARS-CoV-2 infection
Uppsala University

Researchers at Uppsala University have described the presence, throughout the human body, of the enzyme ACE2.

Newswise: Button Project Lets Children See the Faces Behind the Masks
Released: 5-Aug-2020 2:50 PM EDT
Button Project Lets Children See the Faces Behind the Masks
Vanderbilt University Medical Center

When COVID-19 cases began rising in Nashville, masking became a regular part of life across Vanderbilt University Medical Center and Children’s Hospital as one of several public health safety measures to protect employees and patients from potential COVID-19 exposure. Children’s Hospital decided to get creative to ensure that the 1,700 children and families who visit the hospital and clinics each day can see that the same friendly faces they’ve always known still exist behind the masks.

Newswise: 239490_web.jpg
Released: 5-Aug-2020 1:45 PM EDT
Massey scientist suggests COVID-19 should be treated as an acute inflammatory disease
Virginia Commonwealth University (VCU)

The COVID-19 pandemic has had detrimental effects on global infrastructure sectors, including economic, political, health care, education and research systems, and there is still no definitive treatment strategy for the disease.

Newswise: Helping protect medical professionals
Released: 5-Aug-2020 1:05 PM EDT
Helping protect medical professionals
Sandia National Laboratories

A media comprised of a sandwich of materials, tested by Sandia National Laboratories, is being manufactured into N95-like respirators that could be used in local medical facilities. The project originated from the urgent need for personal protective equipment when the COVID-19 outbreak began.

Released: 5-Aug-2020 12:50 PM EDT
UCI scientists get ‘initial hit’ in developing drug to treat COVID-19
University of California, Irvine

Irvine, Calif., Aug. 5, 2020 – When the coronavirus pandemic hit, almost everyone at the University of California, Irvine – and colleges across the nation – had to abandon campus. But James Nowick, professor of chemistry, was not a part of that exodus. That’s because his lab, which designs and constructs chemical molecules, had the right equipment to help in the global push to find treatments for COVID-19.


Showing results

110 of 2816

close
2.51797